Levetiracetam impurity and synthesis method thereof

The invention discloses a novel levetiracetam impurity as shown in a formula I and a synthesis method of the novel levetiracetam impurity. The formula I is shown in the description. 本发明公开了种式I所示的左乙拉西坦新杂质以及该杂质的合成方法，

Saved in:
Bibliographic Details
Main Authors ZHU KUN, GONG YULONG, LIN WENQUAN, ZHU YUANXUN, CHEN YONGBI
Format Patent
LanguageChinese
English
Published 17.08.2018
Subjects
ACYCLIC OR CARBOCYCLIC COMPOUNDS
CHEMISTRY
METALLURGY
ORGANIC CHEMISTRY
Online AccessGet full text

Cover

Abstract The invention discloses a novel levetiracetam impurity as shown in a formula I and a synthesis method of the novel levetiracetam impurity. The formula I is shown in the description. 本发明公开了种式I所示的左乙拉西坦新杂质以及该杂质的合成方法，
AbstractList The invention discloses a novel levetiracetam impurity as shown in a formula I and a synthesis method of the novel levetiracetam impurity. The formula I is shown in the description. 本发明公开了种式I所示的左乙拉西坦新杂质以及该杂质的合成方法，
Author ZHU KUN
LIN WENQUAN
ZHU YUANXUN
GONG YULONG
CHEN YONGBI
Author_xml – fullname: ZHU KUN
– fullname: GONG YULONG
– fullname: LIN WENQUAN
– fullname: ZHU YUANXUN
– fullname: CHEN YONGBI
BookMark eNrjYmDJy89L5WQw9kktSy3JLEpMTi1JzFXIzC0oLcosqVRIzEtRKK7MK8lILc4sVshNLcnIT1EA8opS89N4GFjTEnOKU3mhNDeDoptriLOHbmpBfnxqcQHQrLzUknhnP0MDCxMDS1NLI0djYtQAAEYsLtg
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
DocumentTitleAlternate 种左乙拉西坦的杂质及其合成方法
ExternalDocumentID CN108409592A
GroupedDBID EVB
ID FETCH-epo_espacenet_CN108409592A3
IEDL.DBID EVB
IngestDate Fri Jul 19 14:45:28 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language Chinese
English
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_CN108409592A3
Notes Application Number: CN201810468738
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20180817&DB=EPODOC&CC=CN&NR=108409592A
ParticipantIDs epo_espacenet_CN108409592A
PublicationCentury 2000
PublicationDate 20180817
PublicationDateYYYYMMDD 2018-08-17
PublicationDate_xml – month: 08
  year: 2018
  text: 20180817
  day: 17
PublicationDecade 2010
PublicationYear 2018
RelatedCompanies ZHEJIANG HUAHAI TIANCHENG PHARMACEUTICAL CO., LTD
ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD
ZHEJIANG HUAHAI ZHICHENG PHARMACEUTICAL CO., LTD
RelatedCompanies_xml – name: ZHEJIANG HUAHAI ZHICHENG PHARMACEUTICAL CO., LTD
– name: ZHEJIANG HUAHAI TIANCHENG PHARMACEUTICAL CO., LTD
– name: ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD
Score 3.2815406
Snippet The invention discloses a novel levetiracetam impurity as shown in a formula I and a synthesis method of the novel levetiracetam impurity. The formula I is...
SourceID epo
SourceType Open Access Repository
SubjectTerms ACYCLIC OR CARBOCYCLIC COMPOUNDS
CHEMISTRY
METALLURGY
ORGANIC CHEMISTRY
Title Levetiracetam impurity and synthesis method thereof
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20180817&DB=EPODOC&locale=&CC=CN&NR=108409592A
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwED_mFPVNp6LzgwrSt6Jd0w8firi0ZYh2Q6bsbaRtyiqsLWtV9K_3Ejvni76FBJLLweX3u0tyB3CRJIQjquiaYzipRnpppDGWJtpVRJgV24kAZfHaIrQGT-RuYk5a8LL8CyPzhL7L5IhoUTHaey3P63IVxPLk28rqMsqwq7gJxq6nNt6xLupI2KrXd_3R0BtSlVKXhmr4iFxXeDLmde92DdYFjRZ59v3nvviVUv6GlGAHNkY4W17vQutz1oEtuqy81oHNh-bCG5uN7VV7YNzzN15nCxS3ZnMlm5ey8JzC8kSpPnIkclVWKd8VoRVB63iR7sN54I_pQMPVpz9bndJwJahxAO28yPkhKA5HZiSwl5k2Me3YYej2WQbhIjkLJ_YRdP-ep_vf4DFsC7WJKKlun0C7XrzyU4TZOjqT-vkC7v-BPg
link.rule.ids 230,309,786,891,25594,76903
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3fT8IwEL4gGvFNUYP4ayZmb4vCOjofiJGOZSoMYqbhjXSsizNhEDY1-td7rUN80bemTdrrJdfvvmt7B3AeRUQgqjQM27RjgzTj0OA8jozLkPDWhEYSlOVrC7_lPZK7kTUqwcvyL4zKE_qukiOiRU3Q3nN1Xs9XQSxHva3MLsIEu2bXbtB29IIdN2QdCao7nXZ3OHAGTGeszXzdf0BfVzIZ66p5swbrFCmhokpPHfkrZf4bUtxt2BjibGm-A6XP5ypU2LLyWhU2-8WFNzYL28t2weyJN5EnCxQ351Mtmc5V4TmNp5GWfaToyGVJpn1XhNakWydm8R6cud2AeQauPv7Z6pj5K0HNfSins1TUQLMFekYSe7lFiUUnNkfa1zKJkMlZBKEHUP97nvp_g6dQ8YJ-b9y79e8PYUuqUEZMG_QIyvniVRwj5ObhidLVFx6ohCg
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Levetiracetam+impurity+and+synthesis+method+thereof&rft.inventor=ZHU+KUN&rft.inventor=GONG+YULONG&rft.inventor=LIN+WENQUAN&rft.inventor=ZHU+YUANXUN&rft.inventor=CHEN+YONGBI&rft.date=2018-08-17&rft.externalDBID=A&rft.externalDocID=CN108409592A